肝组织活检诊断为药物性肝损伤的肝功能异常患者临床特征分析

Abstract
Figure/Table
References
Related Citation (3)

Download: PDF (809 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the clinical features of drug-induced liver injury(DILI) in patients diagnosed by liver biopsy.Methods A retrospective study was conducted of 179 patients treated at the Fifth Medical Center of Chinese PLA General Hospital between January 2010 and January 2015. All of them had abnormal liver function and were diagnosed with drug-induced liver injuries by liver biopsy that were caused by factors other than common liver disease, including hepatitis A, B, C, E, virus EB, CMV virus infection, autoimmunity liver disease, alcoholic liver disease, nonalcoholic fatty hepatopathy and genetic metabolic liver disease. These patients were assigned to two groups according to liver biopsy results to analyze clinical features and results of biopsy.Results The acute/subacute group consisted of mainly young patients(64.3%), while in the chronic group, elder patients accounted for 53.7%(P＜0.05). In terms of clinical manifestations, such as fatigue, liver discomfort, fever and skin pruritus, there was no difference between those two groups (P＞0.05).Poor appetite(50.0％ vs 30.9％) and dark urine(58.9％ vs 30.5％) were much more common in the acute/sub-acute group than in the chronic group(P＜0.05). In terms of biochemical detection of liver function, levels of ALT, AST, TBIL and DBIL were significantly higher in the acute/sub-acute group than in the chronic group (P＜0.01), but there was no obvious difference in terms of ALP, GGT or ANA. There was no difference in manifestations of cholestasis biopsy between the two groups. The acute/subacute group had more biopsy manifestations of the mixed type while the chronic liver injury group had more cases of hepatocellular injury.Conclusions The seniors are vulnerable to chronic drug-induced liver injuries, especially i hepatocellular injuries. Patients with recurring and hepatic dysfunction for unknown reasons must be alert to potential chronic drug-induced liver injuries.

Key words： drug-induced liver injury abnormal liver function liver biopsy

Received: 08 October 2018

ZTFLH:

R573.1

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	XU Jiaojiao
	KANG Yanyan
	CHEN Yongwei
	HE Tingting

Cite this article:

XU Jiaojiao,KANG Yanyan,CHEN Yongwei等. Clinical features of abnormal liver function in patients diagnosed with drug-induced liver injury by liver biopsy[J]. Med. J. Chin. Peop. Armed Poli. Forc., 2019, 30(3): 240-243.

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2019/V30/I3/240

[1]	Sumeet K A, Harshad D, John E, et al. Burden of liver diseases in the world[J]. Hepatology, 2019, 70(1):151-157 .
[2]	Chalasani N P, Hayashi P H, Bonkovsky H L, et al. ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury[J]. Am J Gastroenterol, 2014, 109(7): 950-967.
[3]	Lu R J, Zhang Y, Tang F L, et al. Clinical characteristics of drug-induced liver injury and related risk factors [J]. ExpTher Med, 2016, 12(4): 2606-2616.
[4]	Lee B M, Lee W C, Jang J Y, et al. Clinical features of drug-induced liver injury according to etiology [J]. J Korean MedSci, 2015, 30(12): 1815-1820.
[5]	Aithal G P, Watkins P B, Andrade R J, et al. Case definition and phenotype standardization in drug-induced liver injury[J]. Clin Pharmacol Ther, 2011, 89(6): 806-815.
[6]	Chen Minjun, Bisgin H, Tong Lillian,et al. Toward predictive models for drug induced liver injury in humans:are we there yet [J]. Biomarkers Med,2014,8(2):201-213.
[7]	Kubo S, Matsuzaki K, Sek T, et al.Severe acute hepatitis in a printing company worker: a case study[J]. J Occup Health, 2015,57(1):87-90.
[8]	Davern T J. Drug -induced liver disease [J] . Clin Liver Dis ,2012,16(2):231-245.
[9]	Amadid H, Schiodt FV. Hypoxic hepatitis [J]. Ugeskr Lawger, 2014, 176(4):2278-2280.
[10]	张颖,张赣生,郑松柏,等.中国老年人急性药物性肝损伤879例临床荟萃分析[J]. 中华老年多器官疾病杂志,2013,12(6):434-437.
[11]	任张青,王进海,郭晓燕,等. 2005-2014年我国药物性肝损伤临床综合分析[J]. 药物流行病学杂志,2016,25(5):284-289.
[12]	高果,江红,臧国庆,等.不明原因肝功能异常78例肝穿刺活检分析[J]. 肝脏,2017,22(7):608-610.
[13]	胡锡琪.药物性肝损伤组织病理学评分再探讨[J]. 肝脏,2014,19(8):577-579.
[14]	孙艳华,林之莓,项晓刚,等.不明原因肝功能异常2510例临床资料分析[J]. 肝脏,2016,21(8):623-625.
[15]	陈敏敏,郑松柏.老年人药代动力学的特点[J].老年医学与保健,2011,17(3):189-191.
[16]	柏兆方,高源,左晓彬,等.免疫调控与特异质型药物性肝损伤发生机制研究进展[J]. 药学学报, 2017(7):1019-1026.